نتایج جستجو برای: single daily dose

تعداد نتایج: 1301527  

2016
Julian Steitz Patrick Naumann Silke Ulrich Matthias F. Haefner Florian Sterzing Uwe Oelfke Mark Bangert

INTRODUCTION The efficacy of radiation therapy treatments for pancreatic cancer is compromised by abdominal motion which limits the spatial accuracy for dose delivery - especially for particles. In this work we investigate the potential of worst case optimization for interfractional offline motion mitigation in carbon ion treatments of pancreatic cancer. METHODS We implement a worst case opti...

HASHEMI GHAMAR, MOHAMMAD HOSSEIN FALLAHZADEH,

In order to avoid using cytotoxic drugs and to minimize prednisolone side effects in frequent relapsing or steroid-dependent idiopathic nephrotic syndrome, 35 patients, 3 to 15 (mean= 8.1) years of age, were studied. While in remission for at least 6 weeks, the dose of prednisolone was reduced to 0.1-0.37 (mean= 0.23) mg/kg/day as a single dose for 12 to 72 (mean= 27.6) months. It was follo...

Journal: :Diabetes care 2009
David Sandercock Marilou Cramer Jacqueline Wu Yu-Kun Chiang Victor Biton Michelle Heritier

Efficacy and tolerability in a double-blind, randomized, controlled clinical trial A randomized, double-blind, placebo controlled study was conducted in 147 patients to determine the efficacy and safety of gabapentin extended release (g-ER) in treating pain associated with diabetic peripheral neuropathy (DPN). Gabapentin, an immediate-release formulation, has demonstrated clinical efficacy in D...

Journal: :Clinical cancer research : an official journal of the American Association for Cancer Research 2014
Jordi Rodon Hussein A Tawbi Anne L Thomas Ronald G Stoller Christian P Turtschi Jose Baselga John Sarantopoulos Devalingam Mahalingam Yaping Shou Melissa A Moles Lin Yang Camille Granvil Eunju Hurh Kristine L Rose Dereck D Amakye Reinhard Dummer Alain C Mita

PURPOSE This phase I trial was undertaken to determine the maximum tolerated dose (MTD), dose-limiting toxicities (DLT), safety, tolerability, pharmacokinetics, pharmacodynamics, and preliminary antitumor activity of the novel smoothened inhibitor sonidegib (LDE225), a potent inhibitor of hedgehog signaling, in patients with advanced solid tumors. EXPERIMENTAL DESIGN Oral sonidegib was admini...

Journal: :The Journal of antimicrobial chemotherapy 2004
Jill P Adler-Moore Jon A Olson Richard T Proffitt

OBJECTIVES This study was done to determine whether high dose AmBisome (4-20 mg/kg), given intermittently, could reduce the frequency of dosing needed to treat murine systemic candidiasis when compared with conventional daily treatment. METHODS Mice were immunosuppressed with cyclophosphamide every 3 days, beginning day -3 before challenge with log(10) 5.0 cfu Candida albicans. Treatment was ...

Journal: :Indian journal of experimental biology 1999
R K Parshad

Effects of intraperitoneal injections of sodium selenite (2.0 and 4.0 mg/kg body weight) to normally cycling female albino Wistar rats daily for 30 days, and of single injection either during proestrous or oestrous and at each stage of the 4-day oestrous cycle were determined on oestrous cyclicity, ovarian follicles, ovulation, implantation and pregnancy outcome on day 14 of gestation. Administ...

Journal: :The American journal of tropical medicine and hygiene 2005
Hoda A Farid Ragaa E Hammad Marah M Hassan Reda M R Ramzy Maged El Setouhy Gary J Weil

We studied effects of combined diethylcarbamazine (DEC) and albendazole (ALB) treatment on Wuchereria bancrofti microfilaria (MF) uptake and development of infective larvae (L3) in Culex pipiens. Consenting Egyptian adults with microfilaremia (MF > 300/mL) were treated with one or seven daily doses of DEC/ALB. Laboratory-reared mosquitoes were fed on subjects before and after treatment. MF upta...

Journal: :Clinical cancer research : an official journal of the American Association for Cancer Research 2005
Bart C Kuenen Giuseppe Giaccone Rita Ruijter Astrid Kok Casper Schalkwijk Klaas Hoekman Herbert M Pinedo

PURPOSE SU6668 is a tyrosine kinase inhibitor which targets platelet-derived growth factor receptor-beta, fibroblast growth factor receptor-1, vascular endothelial growth factor receptor-2, and KIT. We did a phase I study to define the maximum tolerated dose and to assess the pharmacokinetics of SU6668 administered orally thrice daily with food. PATIENTS AND METHODS Patients with histological...

2014
Hiromi Iitsuka Tomoaki Tokuno Yoko Amada Hiroshi Matsushima Masataka Katashima Taiji Sawamoto Shin Takusagawa Marcel van Gelderen Takanori Tanaka Hideo Miyahara

BACKGROUND Mirabegron is a human β3-adrenoceptor agonist for the treatment of overactive bladder. The pharmacokinetic profile of mirabegron has been extensively characterized in healthy Caucasian subjects. OBJECTIVE The objective of this study was to evaluate the pharmacokinetics, dose-proportionality, and tolerability of mirabegron following single and multiple oral doses in healthy Japanese...

Journal: :Advances in experimental medicine and biology 1977
R A Sturge J T Scott E B Hamilton S P Liyanage A S Dixon J Davies C Engler

Naproxen 750 mg as a single dose followed by 250 mg three times daily has been compared with phenylbutazone 200 mg four times daily for 48 hours followed by 200 mg three times daily for treatment of acute gout in an open study on 41 patients. The drugs were equally effective with few and relatively mild side effects. Naproxen is a useful alternative agent for the treatment of acute gout.

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید